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IN RESPONSE: Dr. Wilfley and colleagues highlight several
critical gaps in the evidence base on effective treatments for
patients with BED, including information about treatment du-
rability, generalizability, and tradeoffs between benefits and
harms. They recommend longer-term outcome studies to ad-
dress such shortcomings, including comparative effectiveness
studies, and express concern about the adverse effects of
some pharmacologic agents. In many respects, their observa-
tions echo our conclusions about treatment efficacy and
harms as presented in our article and comparative effective-
ness (1). Nonetheless, we note some important caveats for
readers to consider.
First, today's evidence base is sufficient only to single
out CBT as a first-line option for psychological treatment—
not because of the methods or outcomes of our meta-
analyses but because of the number, size, and diversity
of the studies available. We followed best practices for sys-
tematic reviews (2) by framing the key questions for analyses
in terms of internationally known PICOTS (population, inter-
vention, comparator, outcomes, timing of outcomes measure-
ment, and setting) (3), critically deliberating a priori study in-
clusion and exclusion criteria, and setting a minimum
threshold (that is, at least 3 studies with reasonably homoge-
neous populations and outcomes) for pooled analysis. As for
pharmacologic studies, considerable literature offers prece-
dents for analyzing second-generation antidepressants as a
class, and our analysis of lisdexamfetamine was limited to the
therapeutic doses approved by the U.S. Food and Drug
Administration.
Second, we agree that CBT and IPT have shown consid-
erable promise in conferring benefits that carry over beyond
the active treatment period. Nonetheless, long-term data
from available published studies are insufficient or overly di-
verse for pooled analysis of comparisons of psychological
treatments. Of the 2 included trials of CBT versus IPT, 1 com-
pared CBT with IPT delivered via therapist-led group treat-
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Finally, we respectfully disagree that psychological treat-
ments pose only minimal risks; rather, evidence is lacking be-
cause potential harms have not been widely conceptualized 
or measured.
Drawing from our own clinical experiences and past and 
present research, we endorse psychotherapy, especially CBT, 
for patients with BED. We consider IPT to be a highly promis-
ing treatment option. What we cannot conclude is whether 
specialist psychological treatment should have any priority 
over pharmacologic treatment on the basis of comparative 
effectiveness or risk. Studies addressing that question directly 
simply have not been done. The good news is that clinicians, 
and their patients, have several proven options for therapy for 
BED that can accommodate their shared treatment goals and 
patients' preferences and values. On these matters, we are 
certain that Dr. Wilfley and colleagues are in complete agree-
ment with us.
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